Neogen Corporation (NEOG)
NASDAQ: NEOG · Real-Time Price · USD
6.16
-0.05 (-0.81%)
Oct 28, 2025, 4:00 PM EDT - Market closed
Neogen Revenue
Neogen had revenue of $209.19M in the quarter ending August 31, 2025, a decrease of -3.58%. This brings the company's revenue in the last twelve months to $886.89M, down -2.77% year-over-year. In the fiscal year ending May 31, 2025, Neogen had annual revenue of $894.66M, down -3.20%.
Revenue (ttm)
$886.89M
Revenue Growth
-2.77%
P/S Ratio
1.51
Revenue / Employee
$298,213
Employees
2,974
Market Cap
1.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 894.66M | -29.56M | -3.20% |
| May 31, 2024 | 924.22M | 101.78M | 12.37% |
| May 31, 2023 | 822.45M | 295.29M | 56.01% |
| May 31, 2022 | 527.16M | 58.70M | 12.53% |
| May 31, 2021 | 468.46M | 50.29M | 12.03% |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
NEOG News
- 19 days ago - Animal Tester Neogen Sticks To Annual Forecast Despite Tariffs - Benzinga
- 19 days ago - Neogen Corporation (NEOG) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Neogen Announces First-Quarter 2026 Results - Business Wire
- 21 days ago - Top Wall Street Forecasters Revamp Neogen Expectations Ahead Of Q1 Earnings - Benzinga
- 4 weeks ago - Neogen® Renews Official Sponsorship with US Equestrian to Continue Advancing Equine Health Education - Business Wire
- 5 weeks ago - Neogen Announces First-Quarter Earnings Release Date - Business Wire
- 6 weeks ago - Neogen® Announces CFO Transition Plan - Business Wire
- 7 weeks ago - Neogen: A Nibble With The Sale Of An Out-Of-The-Money Call That Can Be Rolled Forward - Seeking Alpha